Bioretec clarifies its 2026-2028 financial target regarding the sales margin

Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EESTHELSINKI, May 13, 2026 /PRNewswire/ -- To be aligned with industry reporting standards, Bioretec will transition to reporting an adjusted ...
Yahoo Finance

Change negotiations completed at Bioretec

TAMPERE, Finland, Dec. 4, 2025 /PRNewswire/ -- On November 12, 2025, Bioretec announced the start of statutory change negotiations under the Finnish Act on Co-operation within Undertakings, concerning ...

Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors

At its constitutive meeting held after the Annual General Meeting, the Board of Directors of Bioretec Ltd elected Kustaa Poutiainen as the Chairperson of the Board and David Gill as the Deputy ...
Morningstar

Bioretec Ltd's Financial Statements and Annual Report 2025 published

Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with fully biodegradable implant technologies. The company has built unique ...
Yahoo Finance

Inside information: Bioretec updates its financial targets

TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec Ltd announced today, 4 October 2024, that Bioretec's board of directors had decided to update the company's product development strategy by ...
Morningstar

Bioretec Ltd's resolutions of the Extraordinary General Meeting | Morningstar

Bioretec Ltd's (the " Company ") Extraordinary General Meeting was held on Friday 27 March 2026 as a real-time virtual meeting in accordance with Chapter 5, Section 16, Subsection 3 of the Finnish ...
Yahoo Finance

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the ...
PR Newswire

Correction: Bioretec Ltd's Half-year report 2025

Bioretec's Board of Directors appointed MBA Sarah van Hellenberg Hubar-Fisher as the company's interim CEO as of 15 May 2025, following the resignation of CEO Alan Donze. Mirva Ekman, M.Sc.
Nasdaq

Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin

(RTTNews) - Bioretec Oy (0TN.F, BRETEC.HE) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable ...
Mena FN

Inside Information: Bioretec Ltd's Board Of Directors Resolved On A Rights Issue Of Approximately EUR 9.2 Million And Publishes The Terms And Conditions Of The Fully Guaranteed ...

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ...
Healio

Bioretec receives FDA market authorization for RemeOs trauma screw

Please provide your email address to receive an email when new articles are posted on . Bioretec has received FDA market authorization for its RemeOs trauma screw. The bioresorbable metal implant is ...